BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 17218778)

  • 1. Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells.
    Roepke M; Diestel A; Bajbouj K; Walluscheck D; Schonfeld P; Roessner A; Schneider-Stock R; Gali-Muhtasib H
    Cancer Biol Ther; 2007 Feb; 6(2):160-9. PubMed ID: 17218778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
    Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
    J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymoquinone, a bioactive component of black caraway seeds, causes G1 phase cell cycle arrest and apoptosis in triple-negative breast cancer cells with mutant p53.
    Sutton KM; Greenshields AL; Hoskin DW
    Nutr Cancer; 2014; 66(3):408-18. PubMed ID: 24579801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells.
    Arafa el-SA; Zhu Q; Shah ZI; Wani G; Barakat BM; Racoma I; El-Mahdy MA; Wani AA
    Mutat Res; 2011 Jan; 706(1-2):28-35. PubMed ID: 21040738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymoquinone inhibits growth of human medulloblastoma cells by inducing oxidative stress and caspase-dependent apoptosis while suppressing NF-κB signaling and IL-8 expression.
    Ashour AE; Ahmed AF; Kumar A; Zoheir KM; Aboul-Soud MA; Ahmad SF; Attia SM; Abd-Allah AR; Cheryan VT; Rishi AK
    Mol Cell Biochem; 2016 May; 416(1-2):141-55. PubMed ID: 27084536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymoquinone-induced antitumor and apoptosis in human lung adenocarcinoma cells.
    Samarghandian S; Azimi-Nezhad M; Farkhondeh T
    J Cell Physiol; 2019 Jul; 234(7):10421-10431. PubMed ID: 30387147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism.
    Gali-Muhtasib H; Diab-Assaf M; Boltze C; Al-Hmaira J; Hartig R; Roessner A; Schneider-Stock R
    Int J Oncol; 2004 Oct; 25(4):857-66. PubMed ID: 15375533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bupivacaine and Lidocaine Induce Apoptosis in Osteosarcoma Tumor Cells.
    Mirshahidi S; Shields TG; de Necochea-Campion R; Yuan X; Janjua A; Williams NL; Mirshahidi HR; Reeves ME; Duerksen-Hughes P; Zuckerman LM
    Clin Orthop Relat Res; 2021 Jan; 479(1):180-194. PubMed ID: 33009230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells.
    El-Mahdy MA; Zhu Q; Wang QE; Wani G; Wani AA
    Int J Cancer; 2005 Nov; 117(3):409-17. PubMed ID: 15906362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymoquinone induces apoptosis of human epidermoid carcinoma A431 cells through ROS-mediated suppression of STAT3.
    Park JE; Kim DH; Ha E; Choi SM; Choi JS; Chun KS; Joo SH
    Chem Biol Interact; 2019 Oct; 312():108799. PubMed ID: 31433961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
    Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
    Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway.
    Peng L; Liu A; Shen Y; Xu HZ; Yang SZ; Ying XZ; Liao W; Liu HX; Lin ZQ; Chen QY; Cheng SW; Shen WD
    Oncol Rep; 2013 Feb; 29(2):571-8. PubMed ID: 23232982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes.
    Gali-Muhtasib HU; Abou Kheir WG; Kheir LA; Darwiche N; Crooks PA
    Anticancer Drugs; 2004 Apr; 15(4):389-99. PubMed ID: 15057144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel quinazoline HMJ-30 induces U-2 OS human osteogenic sarcoma cell apoptosis through induction of oxidative stress and up-regulation of ATM/p53 signaling pathway.
    Chiu YJ; Hour MJ; Lu CC; Chung JG; Kuo SC; Huang WW; Chen HJ; Jin YA; Yang JS
    J Orthop Res; 2011 Sep; 29(9):1448-56. PubMed ID: 21425328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferonalpha enhances etoposide-induced apoptosis in human osteosarcoma U2OS cells by a p53-dependent pathway.
    Yuan XW; Zhu XF; Liang SG; Fan Q; Chen ZX; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
    Life Sci; 2008 Feb; 82(7-8):393-401. PubMed ID: 18191951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of G2/M phase cell cycle arrest and apoptosis by ginsenoside Rf in human osteosarcoma MG‑63 cells through the mitochondrial pathway.
    Shangguan WJ; Li H; Zhang YH
    Oncol Rep; 2014 Jan; 31(1):305-13. PubMed ID: 24173574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
    PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymoquinone Augments Methotrexate-Induced Apoptosis on Osteosarcoma Cells.
    Sanapour N; Malakoti F; Shanebandi D; Targhazeh N; Yousefi B; Soleimanpour J; Majidinia M
    Drug Res (Stuttg); 2022 Apr; 72(4):220-225. PubMed ID: 35385883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymoquinone induces cell death in human squamous carcinoma cells via caspase activation-dependent apoptosis and LC3-II activation-dependent autophagy.
    Chu SC; Hsieh YS; Yu CC; Lai YY; Chen PN
    PLoS One; 2014; 9(7):e101579. PubMed ID: 25000169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics.
    Engert F; Kovac M; Baumhoer D; Nathrath M; Fulda S
    Oncotarget; 2017 Jul; 8(30):48794-48806. PubMed ID: 27447864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.